From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
Year: 2024
Type: article
Source: Nature Metabolism
Authors: Cynthia L. Hsu, Rohit Loomba
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Health and Human Services, American Association for the Study of Liver Diseases, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences
Awards: A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?, G1785535472, G1854501754, DETECTION AND MODELS OF TOXICANT EXPOSURE, G3199503829, Non-invasive screening of diabetics for advanced fibrosis due to NAFLD, G4880044011, G5643601509, Ancillary Studies of NAFLD and NASH in HIV infected Adults, QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD, G723437978, UC San Diego Clinical and Translational Research Institute, Role of gut microbial ethanol production in alcohol use disorder and alcohol-associated liver disease, San Diego Digestive Diseases Research Center, Southern California Research Center for ALPD and Cirrhosis, Clinical Research on Nonalcoholic Fatty Liver Disease, San Diego Cirrhosis Clinical Research Network
OpenAlex ID: W4391997845
